Although the development of chemically induced, self-assembled protein-based materials is rapidly expanding, methods for directing their assembly in solution are sparse, and problems of population heterogeneity remain. By exerting control over the assembly of advanced protein structures, new classes of ordered protein nanomaterials become feasible, affecting numerous applications ranging from therapeutics to nanostructural engineering. Focusing on a protein-based method for modulating the stability of a chemically induced dihydrofolate reductase (DHFR) dimer, we demonstrate the sensitivity of a methotrexate competition assay in determining the change in DHFR-DHFR binding cooperativity via interfacial mutations over a 1.3 kcal/mol range. This represents a change of more than 40% of the dimer complex binding energy conferred from protein-protein cooperativity (~3.1 kcal/mol). With the development of this investigative system and refinement of protein-based techniques for complex stability modulation, the directed assembly of protein nanomaterials into heterocomplexes and a concomitant decrease in population heterogeneity becomes a realizable goal.
INTRODUCTION
Molecular recognition plays a key role in defining the protein and nucleic acid interactions that create and operate living systems. The library of known protein-protein interactions has been extensively studied in an effort to uncover its diverse role in biological processes as well as develop therapeutic tools that can exploit such interactions for the treatment of disease (Salwinski et al., 2004; Keskin et al., 2008; Reilly et al., 2009) . A great deal of effort has been put forth toward delineating the composition and role of interfacial amino acids (Glaser et al., 2001; Ofran and Rost, 2003) , the contribution of thermodynamic forces to protein complex stability (Hendsch and Tidor, 1999; Sheinerman et al., 2002) , and the mechanisms by which two proteins go about recognizing each other in a veritable sea of macromolecules (Young et al., 1994; Lo Conte et al., 1999; Kobe and Kajava, 2001) . Recent advances in bioinformatics have led to extensive mining of structural complementarity and sequence similarity data; however, the peculiarities of each protein system have made model generation quite difficult (Walls and Sternberg, 1992; Marcotte et al., 1999; Uetz et al., 1999) .
Protein interfaces have been well studied, and it is now understood that the composition of the interface is very similar to the rest of the protein surface (Jones and Thornton, 1996) . Although charged residues are somewhat less common at interfaces due to the net loss of energy due to desolvation, hydrophobic residues such as Phe, Trp, and Met are prevalent in many cases (Lo Conte et al., 1999; Elcock and McCammon, 2001 ). The sidechain packing at protein interfaces is relatively compact, and this defining characteristic can often be used to differentiate true protein interfaces from crystallographic packing artifacts (Young et al., 1994; Lo Conte et al., 1999) . This packing density relates closely to the common incorporation of hydrophobic residues at interfaces as the residue sidechains orient in the densest possible manner to minimize contact with solvent (Vaskar and Aflalo, 1994; Tsai et al., 1997; Crowley et al., 2001) .
It has been shown that protein complex binding energy is frequently localized in interfacial hotspots, where several key residue interactions contribute the majority of the binding energy (Clackson and Wells, 1995; Bogan and Thorn, 1998; Reichmann et al., 2007; Geppert et al., 2011; Cukuroglu et al., 2012) . Extensive effort has been directed toward investigating the nature of these hotspots-notably by methods such as alanine scanning mutagenesis, in which residues are replaced serially with alanine in an effort to quantitate their contributions to overall binding energy (Bogan and Thorn, 1998; Thorn and Bogan, 2001; Hall et al., 2011; Liu et al., 2011) . On the theoretical front, computational alanine scanning (Massova and Kollman, 1999) , free energy decomposition (Gohlke and Case, 2004) , and molecular dynamics (Chowdhury et al., 2009 ) have become effective methods for the determination of individual residue contributions to binding energy, resolved even to net contributions from the backbone and sidechain independently. The realization that binding energies are localized in this manner is an important discovery having the potential to drive research toward the design of tailored protein interfaces wherein practical structural and functional modifications may be achieved.
Complementing theoretical work, bench work by Cunningham and Wells revealed that replacement of key residues at the recognition site of human growth hormone (hGH) with alanine modified its affinity for its biological targets-the hGH and prolactin receptors Lowman et al., 1991) . Although the wild-type (WT) enzyme binds each with equivalent affinity, replacement of the key residues yielded a 34 000-fold selectivity for the hGH receptor. Other investigations have utilized the mass reconfiguration of electrostatic interactions as well as the replacement of buried polar residues with nonpolar isosteres (Hendsch et al., 1996; Hendsch et al., 2001) . Further work assessing the interplay of electrostatic and hydrophobic interactions has also shown the stabilizing and destabilizing effects of these modifications (Camacho et al., 2006; Johnson et al., 2011; Lewis and Kuhlman, 2011) .
In the context of therapeutics, protein interface remodeling is an attractive pursuit as the selective inhibition of protein complexation represents the ability to control a wide array of biological mechanisms (Mandell and Kortemme, 2009; Karanicolas et al., 2011; Smith and Kortemme, 2011) . Small molecule inhibition would achieve this goal, in effect reshaping the interface to render it noncomplementary (Arkin and Wells, 2004; Sillerud and Larson, 2005; Garner and Janda, 2011; Meireles and Mustata, 2011) . However, this has remained an elusive target due to the topologically bland surfaces present at protein interfaces that often preclude selectivity. Protein surfaces simply lack the key features amenable to rational design that are found in enzyme binding pockets, such as residues that sterically or electrostatically favor the binding of a small molecule (Cochran, 2000) . As such, it remains difficult to control protein association at surfaces with smallmolecule-based techniques.
With the advent of chemically induced dimerization (CID), it has become possible to control the formation of a protein complex. Since the landmark work of Schrieber et al. (Spencer et al., 1993) , a number of dimerization systems have been well studied, resulting in a platform technology or toolkit that serves many technical and investigative applications. Examples of these applications include the selective activation of signal transduction pathways (Spencer et al., 1993; Farrar et al., 1996; Luo et al., 1996; Cheng et al., 2005) , localized control over transcription (Nyanguile et al., 1997; Biggar and Crabtree, 2000; Biggar and Crabtree, 2001; Rowe et al., 2007) , posttranslational control over protein structure and function (Mootz and Muir, 2002; Mootz et al., 2003; Xu and Evans, 2005; Schwartz et al., 2007; Stankunas and Crabtree, 2007) , protein-ligand proximity sensing (George et al., 2004; Keppler et al., 2004; Lemercier et al., 2007) , and yeast three-hybrid-based bioscreening (Licitra and Liu, 1996; Kley, 2004) . Much like their investigative counterparts, therapeutic CID systems exert switchable control over signal transduction and gene expression and can also physically inhibit protein-protein interactions that are known to cause disease, such as amyloid plaque formation in Alzheimer's disease (Neff and Blau, 2001; Whitney et al., 2001; Gestwicki et al., 2004; Carlotti et al., 2005; Zhao et al., 2005; Kitov et al., 2008) . Last, chemically induced protein complexation has become a major player in the development of protein-based nanostructures ranging from biotin-linked streptavidin nanoarrays to more elegant tubular and ring-based structures, some of which even retain catalytic activity (Ringler and Schulz, 2003; Carlson et al., 2006; Ballister et al., 2008; Chou et al., 2008) . A comprehensive review of the myriad studies and applications of chemically induced dimerization systems has been previously published , but a common theme is the fusion of proteins of interest to a CID "core," effectively creating a proximity switch for the proteins of interest. Given the broad applications of chemically induced dimerization, it becomes easy to see the importance of fine control over the assembly of this core protein complex.
Of the CID systems available, we have focused our investigations on the chemically induced dihydrofolate reductase (DHFR) dimer, first described by Hu and coworkers (Kopytek et al., 2000 The DHFR dimer is selectively assembled via the addition of a bivalent inhibitor of DHFR-bis-MTX-C9 (Figure 1) (Carlson et al., 2003) . Our characterization of this system has uncovered several key aspects that highlight its suitability for investigating the effects of interfacial point mutations on DHFR dimer stability (Carlson et al., 2003) . First, dimerization only occurs in the presence of a specific ligand; second, the complex can only be disassembled via the addition of a competitive inhibitor of the dimerizer; third, the thermodynamics of complex assembly have been well characterized. These factors combine to yield a system well suited to the study of the weak intermolecular interactions that dominate transient protein complexation (Tang et al., 2006; Morell et al., 2007) . In addition, the relatively small surface area of the DHFR dimer interface (520 Å 2 ) is beneficial because few mutations are necessary to yield relevant data concerning modified dimer behavior.
A number of studies have emerged where assembling proteins into advanced materials is achieved through chemically induced dimerization (Dotan et al., 1999; Padilla et al., 2001; Ringler and Schulz, 2003; Rele et al., 2007; Ballister et al., 2008) . A key aspect of utilizing chemically induced dimerization for protein nanostructural assembly is control over the composition and assembly of the structure. The simplest nanostructure can be envisioned as a complex between two proteins-A and B. Based on statistical analysis, if there is no selectivity for homodimer or heterodimer formation, the three species will distribute into a 1:2:1 ratio of AA:AB:BB. Modification of the energetics of any of these three species will perturb this distribution. Ideal selectivity arises from a heterodimer that is substantially lower in energy than that of either homodimer. Analysis of the dimerization energetics, however, reveals that heterodimerization can be significantly favored if just one of the homodimers can be destabilized. This scenario exists naturally for the Jun-Fos transcription factor pair (O'Shea et al., 1989; O'Shea et al., 1992) and has been demonstrated previously in the engineered version of the Arc repressor designed by Tidor and Sauer (Hendsch et al., 2001) . This somewhat counterintuitive principle is illustrated in Figure 2 and represents an avenue of control over protein assembly if the destabilization of homodimers can be accurately characterized.
In our laboratory, we have previously analyzed the importance of ligand conformational equilibria in the context of chemically induced protein dimerization (Carlson et al., 2003) and developed the chemically induced DHFR dimer (DHFR CID) into a homodimeric DHFR 2 fusion-protein-based nanoring (Carlson et al., 2006; Ballister et al., 2008; Chou et al., 2008) . The purpose of the current work is to characterize the role of interresidue cooperativity present in the DHFR dimer interface. Such interactions are exploited in an effort to perturb the stability of the homodimer with the intent to utilize destabilized homodimeric pairings as a basis for heterodimer selectivity and control over the core complex of chemically induced dimerization systems. This protein-directed method differs from present approaches, which rely primarily on ligand-directed methods of achieving heterodimerization (i.e., rapamycin, which intrinsically targets two different proteins) Choi et al., 1996; Liberles et al., 1997) . We believe that the protein-directed method represents a conceptually attractive and novel technique for achieving an improved level of control over protein recognition and induced dimerization.
MATERIALS AND METHODS

General
Kits for site-directed mutagenesis and plasmid DNA preparation were obtained from Stratagene and Invitrogen, respectively. Oligonucleotides used as primers in the mutagenesis reaction were obtained from Integrated DNA Technologies through the University of Minnesota BioMedical Genomics Center. Methotrexate (MTX), NADPH, and MTX-agarose were purchased from Sigma-Aldrich. Anion exchange chromatography was performed using DE52 DEAE cellulose purchased from Whatman. Competent JM-109 Escherichia coli cells were purchased from Promega (Madison, WI). Salts for buffer preparation were of reagent grade and purchased from Mallinckrodt, Fisher, or Sigma-Aldrich. C9-bis-methotrexate (bis-MTX-C9) was synthesized as previously described and purified to ≥99% purity (Carlson et al., 2003) . Dihydrofolate (DHF) was prepared fresh as previously described and stored under argon at À80 C (Blakley, 1960) . All other reagents were of reagent grade or better and purchased from Sigma-Aldrich.
Protein expression, purification, and characterization
To generate mutant E. coli DHFR (ecDHFR) plasmids, the Quickchange kit from Strategene was utilized. In short, complementary primer oligonucleotides bearing the mutations of interest were bound to the parent plasmid, and PCR cycling achieved exponential generation of the mutated plasmid. Mutated plasmid DNA was recovered from transformed XL1-Blue E. coli via the PureLink HiPure Plasmid Miniprep Kit from Invitrogen. Sequencing of the mutated plasmid by the University of Minnesota Microchemical Facility verified the presence of the mutation. Constructs were generated from the pTZwt1-3 plasmid, a gift from the laboratory of Virginia F. Smith, Department of Chemistry, Pennsylvania State University. Oligonucleotides (reverse primer sequence is complementary to forward) used to introduce the mutations are listed below: Mutant plasmid DNA was transformed into the JM109 E. coli expression line. Resulting colonies were inoculated into 4-ml LB broth containing 100 mg/ml ampicillin and grown at 37 C overnight with shaking at 250 rpm. Glycerol was added to cell cultures to a final concentration of 15% (v/v), and stocks were frozen at À80 C until use. For protein expression, starter cultures were prepared using 4-ml LB broth containing 100 mg/ml of ampicillin, 20 mg/ml of trimethoprim, and a 40-ml inoculation of JM-109 cells bearing the plasmid of interest. These cultures were grown for a minimum of 8 hr at 37 C with shaking at 250 rpm before a 500-ml aliquot was transferred to a 50-ml LB containing the same antibiotics and grown for a minimum of 8 hr under the same conditions. A 1-l LB broth containing 100 mg/ml of ampicillin was inoculated with 10 ml of the 50-ml culture and grown for a minimum of 12 hr under the same growth conditions. The cell OD600 typically reaches >1.3 during this period.
Cells were recovered via centrifugation at 7500 g for 15 min, then the cells were lysed via a 30-min incubation in lysis buffer (10 mM KH 2 PO 4 , 100 mM EDTA, 1 mM DTT, 1 mg/ml lysozyme, pH 8.0) containing 1 Complete© protease inhibitor tablet (Roche) and 8 Â 15 sec sonication. The crude lysate was centrifuged at 40 000 g for 40 min at 4 C and the soluble fraction subjected to the addition of 30% (w/v) (NH 4 ) 2 SO 4 over 30 min at 4 C with vigorous stirring. Soluble protein was recovered via centrifugation at 40 000 g for 20 min at 4 C. The lysate was dialyzed against a 4-l equilibration buffer (10 mM KH 2 PO 4 , 0.1 mM EDTA, 0.5 M KCl, 0.5 mM DTT, pH 6.0) for a minimum of 4 hr at 4 C then loaded onto a MTX-agarose column. The bound protein was washed with a high salt buffer (50 mM KH 2 PO 4 , 1 mM EDTA, 1 M KCl, 1 mM DTT, pH 6.0) until the A280 and A260 of the eluate are ≤0.1, at which time, the protein was eluted with a folate elution buffer (50 mM KH 2 PO 4 , 1 mM EDTA, 1 M KCl, 3 mM folic acid, 1 mM DTT, pH 9.0).
Fractions containing DHFR activity as assayed by the DHFR activity assay (see next section) were pooled and dialyzed against 4 Â 4 l of Tris dialysis buffer (50 mM Tris, 1 M NaCl, 1 mM EDTA, 0.5 mM DTT, pH 7.2) for a minimum of 4 hr at 4 C each. A final dialysis against 4 l of DEAE equilibration buffer (10 mM Tris, 1 mM EDTA, 1 mM DTT, pH 7.2) for a minimum of 4 hr at 4 C prepared the protein for loading onto a DEAE anion exchange column. The protein was eluted with a gradient of 0%-40% Buffer B over 300 min then 40%-100% Buffer B over the next 420 min. Buffer A is the equilibration buffer described earlier, and Buffer B is a DEAE elution buffer (10 mM Tris, 1 mM EDTA, 0.5 M KCl, 1 mM DTT, pH 7.2). Collected fractions were measured for A280, A260, and DHFR activity. Purified DHFR was concentrated to~1 mg/ml via Amicon centrifugal ultrafiltration devices and stored at 4 C until use. Typical protein yield was 5-15 mg/l of LB culture. The purity of the proteins was assayed by gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the mass of the WT and mutant proteins was verified via liquid chromatographymass spectrometry.
DHFR activity assay
All steps, except absorbance measurements, were performed at 4 C. MTEN buffer (50 mM MES, 25 nM Tris, 0.1 M NaCl, 25 mM ethanolamine, pH 7.0), NADPH stock solution to a final concentration of 100 mM, and an enzyme sample were mixed to a final volume of 1 ml minus the necessary volume of DHF addition. After a 2-min incubation, a baseline reading at 340 nm was taken to verify zero activity. DHF was then added from a concentrated master stock to a final concentration of 50 mM, the sample was mixed, and the absorbance was read at 340 nm for 1 min. The rate of absorbance decline corresponds to V o in mM/min and was calculated with the known extinction coefficient for the DHFR catalyzed reaction, 11 300 M -1 cm -1 (Taira and Benkovic, 1988) . DHF and NADPH master stock concentrations were estimated spectrophotometrically using the reagents' extinction coefficients at 280 and 340 nm, respectively.
Mutant DHFR K d assay
To assay the affinity for MTX to mutant DHFR, a fluorescence assay measuring the quenching of DHFR fluorescence upon MTX binding was employed. DHFR was diluted to a final concentration of 50 nM in 4-ml MTEN buffer and a baseline fluorescence reading taken, scanning emission from 300 to 400 nm with excitation at 290 nm. Serial additions of MTX were performed, and the emission at 340 nm was recorded. Data were fit using JMP-IN 4.0 (SAS Institute).
Protein gel filtration
Gel filtration samples were prepared as a 5 mM final DHFR concentration in P500 buffer (0.5 M NaCl, 50 mM KH 2 PO 4 , 1 mM EDTA, pH7 .0) with 5% (v/v) glycerol. The samples were loaded on to a Sephadex G-75 column (GE Biosciences) on a Beckman System Gold HPLC and eluted at 0.5 ml/min with P500 buffer. The relative peak intensities were quantitated by absorbance at 280 nm.
Protein concentration assays
Three methods were employed to obtain accurate protein concentration. First, the Bradford assay was used to estimate the concentration of the protein sample. Second, the A280 of diluted DHFR samples was measured, and the extinction coefficient reported by Taira et al. was used to calculate protein concentration (Taira and Benkovic, 1988) . Although this extinction coefficient (31 000 M -1 cm -1 ) may not accurately represent that of mutant proteins with Tyr mutations, it was found that this error did not introduce significant uncertainty into the concentration estimate. Because the purified DHFR samples contained additional small molecules absorbing at 280 nm, gel filtration of the sample yielded a correction for the optical purity (percentage of the total A280 area under the curve). This correction factor was applied to the A280 concentration estimate. Last, DHFR activity was titrated with a known concentration of MTX. The MTX concentration was determined spectrophotometrically using the extinction coefficient at 302 nm (22,100 M -1 cm -1 ) in 0.1 N NaOH (Seeger et al., 1949) .
Competition experiments
The concentrations of both monovalent and bivalent MTX were assayed spectrophotometrically. The extinction coefficient for bis-MTX was estimated at 47 400 M -1 cm -1
, based on the value reported by Rosowsky and coworkers for an MTX g-amide (Rosowsky et al., 1984) . Stock samples of DHFR:bis-MTX were mixed at a stoichiometry of 2:1.05 and incubated in P500 buffer containing 5% glycerol (v/v) for a minimum of 3 hr. The 5% excess of dimerizer was added to ensure complete initial dimerization and was shown to perturb the data far less than other sources of experimental error (data not shown). Complete dimerization of this initial stock was verified by gel filtration chromatography as described. The stock sample was then split, and a range of MTX equivalents was added (0.5 to 2.5Â). Samples were incubated at room temperature for a minimum of 3 hr and assayed via gel filtration. The fraction of dimer present was obtained from corrected integration of the absorbance of the trace at 280 nm. The denaturation curve was then fit as described in the next section to yield the K eq :K c ratio with Mathematica (Wolfram Research) and Microsoft Excel.
Data fitting and error analysis
Throughout the development of the competition assay, it has become apparent that there are four main contributors to error introduced in the estimation of K eq :K c -sample preparation, chromatographic separation, peak area integration, and model data fitting. Of these sources, the first and the last are the most significant. Although careful sample preparation yields reproducible results, any human error (i.e., the miscalculation of MTX added) has the potential to introduce large errors in the final ratio estimate due to the sensitivity of the dimer to small changes in MTX concentration. Repeated gel filtration and peak integration of a single sample yields variations of less than 2%. Due to the complexity of the cubic equation necessary to fit the equilibrium data, the final source of error necessitates an unusual fitting procedure. Because we were unable to derive an analytic solution for Equation (1) (see the Results and Discussion section), Mathematica (Wolfram Research) was used to generate a series of model data based on various K eq :K c ratios that were 0.25 apart (i.e., 0.5, 0.75, 1.0, 1.25, 1.5, etc.). These model data were used to construct a reference table of possible denaturation curves, and the solver module in Microsoft Excel was used to fit the experimental data by selecting the value for K eq :K c that yielded the lowest sum of squared errors (SSE) when compared with a select model data curve. This process was manually repeated using different model curves until the overall lowest SSE value was found, and the corresponding K eq :K c ratio was taken as the observed value. This data fitting procedure was performed on each of the three separate experiments to yield an average observed K eq :K c ratio and the standard deviation.
RESULTS AND DISCUSSION
Mutation scheme selection and K d analysis
Examination of the ecDHFR crystal structure (PDB ID: 4DFR) reveals several candidates for interfacial mutations where residue sidechains interact across the C 2 -symmetric interface. The set of interactions that characterize the dimer interface is summarized in Table 1 . Interbackbone interactions that make up a large part of the interface are not ready targets for mutagenesis. Three pairwise interactions, characterized by primarily sidechain interactions, are presented in Figure 3 . Of these three, the Ala19-Asn23 pair is an attractive target for initial experiments due to the close proximity of their sidechains (3-4 Å), their central location in the dimer interface, and the lack of hydrogen bonding present in the pair. Other targets in Table 1 remain viable for future experiments. These design considerations lead us to hypothesize that mutations utilizing Tyr, Ser, Gln, His, Leu, and Phe would allow for the role of steric, hydrophobic, and electrostatic interactions in the thermodynamic stability of the dimer to be defined.
The residues selected for mutation reside in a loop in DHFR known as the M20 loop, named for the central methionine. This particular loop is significant as it plays a central role in ecDHFR catalysis (Sawaya and Kraut, 1997) . Previous work evaluating the catalytic mechanism of ecDHFR has demonstrated the ability of the enzyme to tolerate substitutions of these two residues without compromising its catalytic activity (Nakamura and Iwakura, 1999) . This evidence further supported our design plans; however, we decided to verify these findings independently.
To more carefully ascertain the effects of mutations in the M20 loop of DHFR, we performed an analysis of the binding affinity for DHFR to MTX via a fluorescence quenching assay (see the Materials and Methods section). The relatively tight binding constant for DHFR (590 pM) (Appleman et al., 1988) leads to a high degree of uncertainty in the estimate of K d due to the narrow window of concentrations leading to a well-fitted binding curve. However, for all mutants except N23F, the K d remains statistically unaltered (Table 2 ). In the case of N23F, the binding affinity shows an apparent fourfold decrease, to approximately 2.9 nM. Reasons for this change in binding affinity may be attributed to long-range interresidue interactions affecting the MTX binding pocket, decreased mobility of the M20 loop, interaction of the hydrophobic residue with the pteridine ring of MTX, or a combination of all three. Although this perturbation in binding affinity may confound competition assay results at lower concentrations, the relatively high concentration of enzyme at which the assay is performed renders this small change irrelevant in the context of our experiment.
Competition experiments
To quantitate the degree to which point mutations stabilize or destabilize the DHFR CID, we have developed a competition assay wherein a pre-equilibrated DHFR CID is denatured with increasing equivalents of MTX, leading to a curve which can be fit to the following equation:
In this equation, K a1 and K a2 are the binding affinities for the first and second bis-MTX binding events and are assumed to 
Residue pairs are classified by the type of contact: sidechainsidechain (S-S), sidechain-backbone (S-B), and backbonebackbone (B-B).
be equal to K aMTX , the DHFR-MTX association constant. K c and K eq are the cooperativity and dimerizer equilibrium constants, respectively; M t is the total added MTX concentration; E t is the total enzyme concentration; and [E 2 D] represents the experimentally observed dimer concentration in terms of fraction dimer. The relative stability of the mutant dimer complexes represents a modification of the value of K c because the K eq for the dimerizer remains constant over the course of the analysis. Therefore, comparison of the K eq :K c ratio found for each mutant with the WT dimer represents the relative effects of point mutations at the interface on cooperativity. These effects can be quantified in terms of energy by utilizing the equation:
A typical competition curve, including model denaturation curves based on several K eq :K c ratios, appears in Figure 4 . It is apparent that the lower the value of K c (and hence the larger the value of the ratio), the less stable the induced dimer, and the easier it is to denature the complex.
Interfacial mutations modulate dimer stability
The results of competition experiments probing the effects of point mutations on the cooperativity in the DHFR CID are summarized in Figure 5. Ratios of the mutant:WT K eq :K c values and the associated energy perturbations are shown in Table 3 and Figure 6 . Globally, the data spans a dynamic range of cooperativity from 0.31-fold to 2.44-fold destabilization. These data reveal several trends. First, all mutations of Ala19 are destabilizing in nature, the least being A19Y, with a mutant:WT ratio of 1.32. Examination of the DHFR crystal structure, which is isomorphous to the dimerized DHFR crystal structure (obtained from Dr Vivian Cody, University at Buffalo, Hauptman Woodward Institute, not yet deposited in the protein data bank) shows that the conformations of Ala19 and Asn23 are oriented such that Ala19 is buried within the protein interface and, as such, is likely less tolerant of modification (Figure 1 ). In fact, it is the introduction of charge-charge repulsion that affects dimerization more severely than steric bulk (A19E with a ratio of 2.26), likely due to the forced close proximity of the negative charges between Glu19 and Asp144 and the inability of Glu19 to shift to a more stable conformation. The A19H mutation also has a pronounced effect, possibly due to the polar character of this mutation, leading to an increased desolvation penalty associated with the formation of the interface. Perturbation of Asn23 yields similar results in terms of chargecharge repulsion (see N23E and N23K); however, most mutations at this position are relatively stabilizing. Examination of the crystal structure indicates that Asn23 is more spatially accommodating than Ala19, as it is capable of reorganizing into the solvent-occupied area surrounding the MTX binding pocket. The implications of this are twofold and are supported by the data. First, the reorientation of charged residues (i.e., Lys23 or Glu23) back into the interior of the interface to escape the desolvation penalty associated with the presence of ionic residues in a solvent-accessible area results in charge-charge repulsion and destabilized pairs. Second, the introduction of hydrophobic residues helps to stabilize the interface as hydrophobic interactions close to solvent can assist in restricting the conformational freedom of the interface, reinforcing interactions in the local area (Vaskar and Aflalo, 1994; Tsai et al., 1997; Crowley et al., 2001) .
In both cases, the histidine mutation raises interesting questions. Given that the pKa of the imidazole of histidine is 6.0, the charge state of this residue will be highly dependent on the environment and could serve as either a hydrogen bond acceptor in the unprotonated state or a charge center if protonated. At pH 7.0 (91% deprotonated), our experiments indicate that the level of destabilization associated with the His mutation (about 1.8-fold) is not as severe as the destabilization associated with other ionic mutations, but not as stabilizing when compared with other hydrophobic residues. Competition experiments at pH 6.0 show a very high level of destabilization (ΔΔG = 0.85 kcal/mol, data not shown) when a greater percentage (50% vs. 9%) of the His sidechain is more likely to be protonated, indicating that charge repulsion is not the only factor responsible for the observed destabilization of the interface at pH 7.0.
Although the effects of charge repulsion at the interface are pronounced, the effects of steric bulk and hydrophobicity are subtle and require in-depth examination. To correlate the general trends associated with steric bulk with change in cooperativity, we assessed total residue 19/23 sidechain volume using the data tables from Tsai et al. (1999) . Surprisingly, in terms of steric bulk, no correlation exists between sidechain volume and ΔΔG (Figure 7 ). Although it is apparent from the crystal structure that mutations at Asn23 have the ability to move relatively freely and are likely insensitive to sidechain bulk, this is particularly surprising for Ala19, given its location deep within the interface. This indicates that although Ala19 may be accommodating enough to permit mutations with increased steric bulk (typical of protein surfaces), ion pairing interactions do not allow for enough spatial freedom on the part of Ala19 to allow for reorganization into a novel, stable conformation. From this, it can be expected that further attempts to destabilize the interface through point mutations should rely primarily on ionic pairing or dipole-dipole interactions.
For exploring correlation between mean 19/23 sidechain hydrophobicity and K eq :K c , we referenced the quantitative measure of hydrophobicity given by Carugo (2003) . A perhaps unsurprising weakly negative (stabilizing) correlation is present in this comparison (Figure 8 ). Many protein interfaces show a high hydrophobic character, with some of the most highly conserved residues at protein interfaces being Trp, Phe, and Met (Elcock and McCammon, 2001) . The low desolvation penalty for a hydrophobic patch on the surface of the protein combined with the tendency to segregate and stabilize away from solvent support the stabilizing effect of introducing hydrophobic residues into the DHFR interface. In contrast, introducing highly charged or polar residues will achieve interface destabilization and serve to decrease K c .
CONCLUSIONS
The series of mutations we have engineered at the DHFR interface have demonstrated an ability to modulate homodimer stability over a range of at least 1.3 kcal/mol or nearly an order of magnitude change in the cooperativity equilibrium constant. Although this modulation falls short of the energy differences obtained for the hGH receptor (6.1 kcal/mol) when considered relative to the comparatively small scale of DHFR-DHFR interface cooperativity, estimated at ΔG ≤ À3.1 kcal/mol, this represents a significant change of~40% (Carlson et al., 2003) .
In the course of our study, we have characterized the effects of representative amino acid point mutations at the DHFR dimer interface. The correlation between sidechain hydrophobicity and increased stability reinforces previous findings that hydrophobic hotspots tend to be conserved among protein interfaces, likely due to a lessened desolvation penalty and a gain in enthalpy associated with tighter binding. However, this affinity is likely to be bounded to an extent by the entropic penalties associated with an increase in the rigidity of the interface (Brooijmans et al., 2002) . In contrast, destabilization of the interface can be best achieved by introducing electrostatic repulsion. Interestingly, given the relatively tight packing of the DHFR-DHFR interface, the introduction of steric bulk seems to be overshadowed by hydrophobic and electrostatic effects and can be dismissed as an effective means of DHFR-DHFR interface modulation.
In terms of the development of an investigative tool, we have demonstrated the utility of the competition assay for testing the effects of point mutations on DHFR dimer cooperativity. Whereas other methods for investigating protein interactions such as phage display (Smith, 1985) and surface plasmon resonance (SPR) exist, which could, in principle, be used for such studies, previous work in our laboratory has indicated problems with both methods. DHFR does not express well as a functional protein on the surface of phage, and although DHFR may be immobilized on an SPR chip and bis-MTX-C9 bound to the protein, the ligand dissociates and washes off the chip before the second DHFR binding event (data not shown). The competition assay represents a highly sensitive method of quantitating mutation effects, especially if the desired outcome is a highly stable interface and increased values for K c . If characterization of a highly destabilized interface is required, although sensitivity is only moderately decreased in the current model, employing a tighter binding dimerizer (i.e., trimethoprim-based) would notably increase precision. Due to the favorable energetics associated with chemically induced dimer formation, even in the absence of protein cooperativity, our approach represents an advantage insomuch as highly destabilizing interactions can still be quantitated. In other native dimer systems, excessive destabilization can yield a completely disrupted complex, precluding high-resolution study of the interface.
Given the range of technologies in which chemically induced dimerization can be utilized (as discussed in the Introduction), it is apparent that improved control over the "core" dimer pair (i.e., DHFR-DHFR) can lead to improved control over the application of interest. The selective dimerization of a DHFR fused to Protein A and a DHFR fused to Protein B will lead to the induced proximity of Protein A to B. Thus, the preparation of heterodimeric pairs would facilitate the design of "copolymeric" protein polymers and nanostructures. For example, the one could envision the preparation of self-assembling bispecific antibody nanorings (Li et al., 2008; Li et al., 2010) This is but one use in a broad spectrum of applications that could be affected via control over the CID core.
For the DHFR dimer, we have found that the A19E and N23K homodimers are more than twofold destabilized relative to the WT homodimer. In the context of the dimer energy landscape, destabilization of either homodimeric species results in a net increase in homodimer free energy and relative stabilization of a heterodimer (O'Shea et al., 1989; O'Shea et al., 1992; Hendsch et al., 2001) . As previously mentioned, although current literature methods rely on primarily ligand-directed methods of effecting heterodimerization Choi et al., 1996; Liberles et al., 1997) , our protein-interface-design-directed method of dimer stability modulation represents an alternative avenue for increased control over protein interactions.
